FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jean Pierre Droz

Research Profile

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Aude Fléchon; Gwenaelle Gravis; F Joly; Stéphane Oudard; D Perol; Damien Pouessel; Frank Priou; Sylvie Zanetta; G Deplanque; Jean Pierre Droz; Pierre Fargeot; C Ferlay; Philippe Beuzeboc; Stéphane Culine
Phase II study of carboplatin and etoposide in patients with anaplastic progressive metastatic castration-resistant prostate cancer (mCRPC) with or without neuroendocrine differentiation: results of the French Genito-Urinary Tumor Group (GETUG) P01 trial.
Véronique Girre; H Arkoub; Martine Puts; C Vantelon; F Blanchard; Jean Pierre Droz; L Mignot
Potential drug interactions in elderly cancer patients.
Catherine Terret; Gilles Albrand; Géraldine Moncenix; Jean Pierre Droz
Karnofsky Performance Scale (KPS) or Physical Performance Test (PPT)? That is the question.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jean Pierre Droz (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Aude Fléchon; Gwenaelle Gravis; F Joly; Stéphane Oudard; D Perol; Damien Pouessel; Frank Priou; Sylvie Zanetta; G Deplanque; Jean Pierre Droz; Pierre Fargeot; C Ferlay; Philippe Beuzeboc; Stéphane Culine
Phase II study of carboplatin and etoposide in patients with anaplastic progressive metastatic castration-resistant prostate cancer (mCRPC) with or without neuroendocrine differentiation: results of the French Genito-Urinary Tumor Group (GETUG) P01 trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(11):2476-81.
2011: Véronique Girre; H Arkoub; Martine Puts; C Vantelon; F Blanchard; Jean Pierre Droz; L Mignot
Potential drug interactions in elderly cancer patients.
Critical reviews in oncology/hematology 2011;78(3):220-6.
2011: Catherine Terret; Gilles Albrand; Géraldine Moncenix; Jean Pierre Droz
Karnofsky Performance Scale (KPS) or Physical Performance Test (PPT)? That is the question.
Critical reviews in oncology/hematology 2011;77(2):142-7.
2010: C Massard; Jean Pierre Droz
[Rare tumours: a new heading in Bulletin du cancer].
Bulletin du cancer 2010;97(9):1031-9.
2010: H Boyle; Aude Fléchon; Jean Pierre Droz
[Uncommon bladder tumours].
Bulletin du cancer 2010;97 Suppl Cancer de la vessie():51-7.
2009: C Terret; Jean Pierre Droz
[Definition and outline on geriatric oncology].
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie 2009;19 Suppl 3():S75-9.
2009: Véronique Girre; Etienne Brain; Hervé Le Caer; Hervé Ghesquières; Patrice Peyrat; Catherine Terret; Jean Pierre Droz
[Clinical management of the most important cancers in older patients].
La Revue du praticien 2009;59(3):347-58.
2009: Jean Pierre Droz
[Geriatric oncology. Integrating the elderly in the program].
La Revue du praticien 2009;59(3):325-7.
2009: Catherine Terret; Elisabeth Castel-Kremer; Gilles Albrand; Jean Pierre Droz
Effects of comorbidity on screening and early diagnosis of cancer in elderly people.
The lancet oncology 2009;10(1):80-7.
2008: Nabil Ismaili; Fadi Elkarak; Pierre Etienne Heudel; Aude Flechon; Jean Pierre Droz
Small cell cancer of the bladder: The Leon-Berard cancer centre experience.
Indian journal of urology : IJU : journal of the Urological Society of India 2008;24(4):494-7.
2008: Jean Pierre Droz; Matti Aapro; Lodovico Balducci
Overcoming challenges associated with chemotherapy treatment in the senior adult population.
Critical reviews in oncology/hematology 2008;68 Suppl 1():S1-8.
2008: Steven I Sherman; Lori J Wirth; Jean Pierre Droz; Michael Hofmann; Lars Bastholt; Renato G Martins; Lisa Licitra; Michael J Eschenberg; Yu-Nien Sun; Todd Juan; Daniel E Stepan; Martin J Schlumberger
Motesanib diphosphate in progressive differentiated thyroid cancer.
The New England journal of medicine 2008;359(1):31-42.
2008: Francesco Caponigro; Giacomo Cartenì; Jean Pierre Droz; Amalia Milano; Wayne B Davis; Patricia Pollard
Phase II study of rubitecan in recurrent or metastatic head and neck cancer.
Cancer chemotherapy and pharmacology 2008;62(2):209-14.
2008: Jean Pierre Droz; Marie-Hélène Rodde-Dunet; Anne Vitoux
[Development of oncogeriatry: national and international strategies].
Bulletin du cancer 2008;95 FMC Onco():F104-7.
2008: Aude Fléchon; Michel Rivoire; Jean Pierre Droz
Management of advanced germ-cell tumors of the testis.
Nature clinical practice. Urology 2008;5(5):262-76.
2008: Helen Boyle; Jean Pierre Droz
[Diagnosis of cancer. Signs, staging and prognosis].
La Revue du praticien 2008;58(8):899-908.
2008: Jean Pierre Droz; Agnieska Chaladaj
Management of metastatic prostate cancer: the crucial role of geriatric assessment.
BJU international 2008;101 Suppl 2():23-9.
2008: Silvio Monfardini; Cesare Gridelli; Lara M Pasetto; Pierre Soubeyran; Jean Pierre Droz; Umberto Basso
Vulnerable and frail elderly: an approach to the management of the main tumour types.
European journal of cancer (Oxford, England : 1990) 2008;44(4):488-93.
2008: Susanne Krege; Jörg Beyer; Rainer Souchon; Peter Albers; Walter Albrecht; Ferran Algaba; Michael Bamberg; István Bodrogi; Carsten Bokemeyer; Eva Cavallin-Ståhl; Johannes Classen; Christoph Clemm; Gabriella Cohn-Cedermark; Stéphane Culine; Gedske Daugaard; Pieter H M De Mulder; Maria De Santis; Maike de Wit; Ronald de Wit; Hans Günter Derigs; Klaus-Peter Dieckmann; Annette Dieing; Jean Pierre Droz; Martin Fenner; Karim Fizazi; Aude Flechon; Sophie D Fosså; Xavier Garcia del Muro; Thomas Gauler; Lajos Geczi; Arthur Gerl; Jose Ramon Germa-Lluch; Silke Gillessen; Jörg T Hartmann; Michael Hartmann; Axel Heidenreich; Wolfgang Hoeltl; Alan Horwich; Robert Huddart; Michael Jewett; Johnathan Keith Joffe; William G Jones; László Kisbenedek; Olbjørn Klepp; Sabine Kliesch; Kai Uwe Koehrmann; Christian Kollmannsberger; Markus Kuczyk; Pilar Laguna; Oscar Leiva Galvis; Volker Loy; Malcolm D Mason; Graham M Mead; Rolf Mueller; Craig Nichols; Nicola Nicolai; Tim Oliver; Dalibor Ondrus; Gosse O N Oosterhof; Luis Paz Ares; Giorgio Pizzocaro; Jörg Pont; Tobias Pottek; Tom Powles; Oliver Rick; Giovanni Rosti; Roberto Salvioni; Jutta Scheiderbauer; Hans-Ulrich Schmelz; Heinz Schmidberger; Hans-Joachim Schmoll; Mark Schrader; Felix Sedlmayer; Niels E Skakkebaek; Aslam Sohaib; Sergei Tjulandin; Padraig Warde; Stefan Weinknecht; Lothar Weissbach; Christian Wittekind; Eva Winter; Lori Wood; Hans von der Maase
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I.
European urology 2008;53(3):478-96.
2008: Susanne Krege; Jörg Beyer; Rainer Souchon; Peter Albers; Walter Albrecht; Ferran Algaba; Michael Bamberg; István Bodrogi; Carsten Bokemeyer; Eva Cavallin-Ståhl; Johannes Classen; Christoph Clemm; Gabriella Cohn-Cedermark; Stéphane Culine; Gedske Daugaard; Pieter H M De Mulder; Maria De Santis; Maike de Wit; Ronald de Wit; Hans Günter Derigs; Klaus-Peter Dieckmann; Annette Dieing; Jean Pierre Droz; Martin Fenner; Karim Fizazi; Aude Flechon; Sophie D Fosså; Xavier Garcia del Muro; Thomas Gauler; Lajos Geczi; Arthur Gerl; Jose Ramon Germa-Lluch; Silke Gillessen; Jörg T Hartmann; Michael Hartmann; Axel Heidenreich; Wolfgang Hoeltl; Alan Horwich; Robert Huddart; Michael Jewett; Johnathan Keith Joffe; William G Jones; László Kisbenedek; Olbjørn Klepp; Sabine Kliesch; Kai Uwe Koehrmann; Christian Kollmannsberger; Markus Kuczyk; Pilar Laguna; Oscar Leiva Galvis; Volker Loy; Malcolm D Mason; Graham M Mead; Rolf Mueller; Craig Nichols; Nicola Nicolai; Tim Oliver; Dalibor Ondrus; Gosse O N Oosterhof; Luis Paz-Ares; Giorgio Pizzocaro; Jörg Pont; Tobias Pottek; Tom Powles; Oliver Rick; Giovanni Rosti; Roberto Salvioni; Jutta Scheiderbauer; Hans-Ulrich Schmelz; Heinz Schmidberger; Hans-Joachim Schmoll; Mark Schrader; Felix Sedlmayer; Niels E Skakkebaek; Aslam Sohaib; Sergei Tjulandin; Padraig Warde; Stefan Weinknecht; Lothar Weissbach; Christian Wittekind; Eva Winter; Lori Wood; Hans von der Maase
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II.
European urology 2008;53(3):497-513.
2008: Stéphane Culine; Andrew Kramar; Christine Théodore; Lionel Geoffrois; Christine Chevreau; Pierre Biron; Binh Bui Nguyen; JF Héron; Pierre Kerbrat; Armelle Caty; Rémi Delva; Pierre Fargeot; Karim Fizazi; Jeannine Bouzy; Jean Pierre Droz
Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(3):421-7.
2008: Nathalie Bonnin; Fadi El Karak; Jean Pierre Droz; Aude Flechon
Pleural metastasis in a patient with bladder cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(2):329-30.
2008: Nabil Ismaili; Sarah Naciri; Said Afqir; Nawfel Mellas; Imane Bekkouch; Sanaa Elmajjaoui; Ouafae Masbah; Nazih Othmani; Aude Flechon; Jean Pierre Droz; Hassan Errihani
A rare case of advanced testicular seminoma in a 78-year-old man managed successfully with carboplatin based chemotherapy: a case report.
Cases journal 2008;1(1):357.
2007: Stéphane Culine; Pierre Kerbrat; Andrew Kramar; Christine Théodore; Christine Chevreau; Lionel Geoffrois; Nguyen Binh Bui; Jean Pény; Armelle Caty; Rémi Delva; Pierre Biron; Karim Fizazi; Jeannine Bouzy; Jean Pierre Droz
Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(5):917-24.
2007: Aude Fléchon; Jean Pierre Droz
[Testis germ cell tumours: which chemotherapy, for which patients?].
Annales d'urologie 2007;41(2):56-67.
2007: Jean Pierre Droz; Andrew Kramar; Pierre Biron; José-Luis Pico; Pierre Kerbrat; Jean Pény; Hervé Curé; Christine Chevreau; Christine Théodore; Jeannine Bouzy; Stéphane Culine
Failure of high-dose cyclophosphamide and etoposide combined with double-dose cisplatin and bone marrow support in patients with high-volume metastatic nonseminomatous germ-cell tumours: mature results of a randomised trial.
European urology 2007;51(3):739-46; discussion 747-8.
2007: Johann S de Bono; Joaquim Bellmunt; Gerhardt Attard; Jean Pierre Droz; Kurt Miller; Aude Flechon; Cora Sternberg; Chris Parker; Gerhard Zugmaier; Veronica Hersberger-Gimenez; Louise Cockey; Malcolm Mason; John Graham
Open-label phase II study evaluating the efficacy and safety of two doses of pertuzumab in castrate chemotherapy-naive patients with hormone-refractory prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(3):257-62.
2006: Aude Flechon; Jean Pierre Droz
Chemotherapy practices and perspectives in invasive bladder cancer.
Expert review of anticancer therapy 2006;6(10):1473-82.
2006: Mojgan Devouassoux-Shisheboran; Catherine Deschildre; Claire Mauduit; Gérard Berger; Frédérique Mejean-Lebreton; Raymonde Bouvier; Jean Pierre Droz; Patrick Fénichel; Mohamed Benahmed
Expression of galectin-3 in gonads and gonadal sex cord stromal and germ cell tumors.
Oncology reports 2006;16(2):335-40.
2006: Michel PAVIC; P Meeus; I Treilleux; Jean Pierre Droz
Malignant teratoma 32 years after treatment of germ cell tumor confined to testis.
Urology 2006;67(4):846.e11-3.
2006: Maoulana Andjilani; Jean Pierre Droz; Mohamed Benahmed; Eric Tabone
Down-regulation of FAK and IAPs by laminin during cisplatin-induced apoptosis in testicular germ cell tumors.
International journal of oncology 2006;28(2):535-42.
2006: Catherine Terret; Gilles Albrand; Martine Jeanton; Philippe Courpron; Jean Pierre Droz
[What's new in geriatric oncology?].
Bulletin du cancer 2006;93(1):119-23.
2005: Aude Fléchon; Stéphane Culine; Christine Théodore; Jean Pierre Droz
Pattern of relapse after first line treatment of advanced stage germ-cell tumors.
European urology 2005;48(6):957-63; discussion 963-4.
2005: Maoulana Andjilani; Jean Pierre Droz; Mohamed Benahmed; Eric Tabone
Alpha6 integrin subunit mediates laminin enhancement of cisplatin-induced apoptosis in testicular tumor germ cells.
International journal of cancer. Journal international du cancer 2005;117(1):68-81.
2005: A-C Piketty; Aude Fléchon; Agnès Laplanche; E Nouyrigat; Jean Pierre Droz; Christine Théodore; Karim Fizazi
The risk of thrombo-embolic events is increased in patients with germ-cell tumours and can be predicted by serum lactate dehydrogenase and body surface area.
British journal of cancer 2005;93(8):909-14.
2005: José-Luis Pico; Giovanni Rosti; Andrew Kramar; H Wandt; V Koza; Roberto Salvioni; Christine Theodore; G Lelli; W Siegert; Alan Horwich; Maurizio Marangolo; W Linkesch; Giorgio Pizzocaro; Hans-J Schmoll; Jeannine Bouzy; Jean Pierre Droz; Pierre Biron
A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(7):1152-9.
2005: Charlotte van Kesteren; Anthe S Zandvliet; Mats O Karlsson; Ron A A Mathôt; Cornelis J A Punt; Jean-Pierre Armand; Eric Raymond; Alwin D R Huitema; Christian Dittrich; Herlinde Dumez; Henri Roché; Jean Pierre Droz; Miroslav Ravic; S Murray Yule; Jantien Wanders; Jos H Beijnen; Pierre Fumoleau; Jan H M Schellens
Semi-physiological model describing the hematological toxicity of the anti-cancer agent indisulam.
Investigational new drugs 2005;23(3):225-34.
2005: Alain Ravaud; Thomas Cerny; Catherine Terret; Jantien Wanders; Binh Nguyen Bui; Dagmar Hess; Jean Pierre Droz; Pierre Fumoleau; Chris Twelves
Phase I study and pharmacokinetic of CHS-828, a guanidino-containing compound, administered orally as a single dose every 3 weeks in solid tumours: an ECSG/EORTC study.
European journal of cancer (Oxford, England : 1990) 2005;41(5):702-7.
2005: Jean-Pierre Lotz; B Bui; F Gomez; Christine Théodore; Armelle Caty; Karim Fizazi; Gwenaelle Gravis; Rémi Delva; Jean Peny; Patrice Viens; B Duclos; T De Revel; Hervé Curé; Joseph GLIGOROV; S Guillemaut; C Ségura; S Provent; Jean Pierre Droz; Stéphane Culine; Pierre Biron
Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of the phase II multicentric TAXIF trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(3):411-8.
2005: Joanna Fombonne; Mojgan Devouassoux-Shisheboran; Raymonde Bouvier; Jean Pierre Droz; Mohamed Benahmed; Slavica Krantic
Analysis of p16INK4A gene promoter in male germ-cell tumors: identification of a new point mutation.
Cancer detection and prevention 2005;29(1):1-7.
2004: Catherine Terret; Gilbert B Zulian; Jean Pierre Droz
Statements on the interdependence between the oncologist and the geriatrician in geriatric oncology.
Critical reviews in oncology/hematology 2004;52(2):127-33.
2004: Karim Fizazi; Stéphane Culine; Andrew Kramar; Robert J Amato; Jeannine Bouzy; Isan Chen; Jean Pierre Droz; Christopher J Logothetis
Early predicted time to normalization of tumor markers predicts outcome in poor-prognosis nonseminomatous germ cell tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(19):3868-76.
2004: Jeany M Rademaker-Lakhai; Catherine Terret; Stephen B Howell; Christiane M Baud; Richard F De Boer; Dick Pluim; Jos H Beijnen; Jan H M Schellens; Jean Pierre Droz
A Phase I and pharmacological study of the platinum polymer AP5280 given as an intravenous infusion once every 3 weeks in patients with solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(10):3386-95.
2004: Catherine Terret; Gilles Albrand; Jean Pierre Droz
Geriatric assessment in elderly patients with prostate cancer.
Clinical prostate cancer 2004;2(4):236-40.
2003: Jean Pierre Droz; Aude Flechon; Catherine Terret
[Metastatic prostate cancer].
La Revue du praticien 2003;53(20):2258-62.
2003: C de la Fouchardière; A Flechon; Jean Pierre Droz
Coagulopathy in prostate cancer.
The Netherlands journal of medicine 2003;61(11):347-54.
2003: Martine Extermann; Gilles Albrand; Hongbin Chen; Sylvie Zanetta; Ronald S Schonwetter; Gilbert B Zulian; Alan Cantor; Jean Pierre Droz
Are older French patients as willing as older American patients to undertake chemotherapy?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(17):3214-9.
2003: Karim Fizazi; Frédéric Rolland; Christine Chevreau; Jean Pierre Droz; Dominique Mery-Mignard; Stéphane Culine; Bernard Escudier
A phase II study of irinotecan in patients with advanced renal cell carcinoma.
Cancer 2003;98(1):61-5.
2003: Luis E Cereceda; Aude Flechon; Jean Pierre Droz
Management of vertebral metastases in prostate cancer: a retrospective analysis in 119 patients.
Clinical prostate cancer 2003;2(1):34-40.
2003: Catherine Terret; S Zanetta; Henri Roché; J H M Schellens; Marije Faber; Jantien Wanders; Miroslav Ravic; Jean Pierre Droz
Phase I clinical and pharmacokinetic study of E7070, a novel sulfonamide given as a 5-day continuous infusion repeated every 3 weeks in patients with solid tumours. A study by the EORTC Early Clinical Study Group (ECSG).
European journal of cancer (Oxford, England : 1990) 2003;39(8):1097-104.
2003: Aude Flechon; Jean Pierre Droz
Management of clinical stage I nonseminomatous germ-cell testis tumors.
Expert review of anticancer therapy 2003;3(1):21-30.
2003: Mojgan Devouassoux-Shisheboran; Claire Mauduit; Eric Tabone; Jean Pierre Droz; Mohamed Benahmed
Growth regulatory factors and signalling proteins in testicular germ cell tumours.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2003;111(1):212-24; discussion 224.
2003: Carsten Bokemeyer; Jörg Thomas Hartmann; Sophie D Fossa; Jean Pierre Droz; Hans-J Schmol; Alan Horwich; Arthur Gerl; Jörg Beyer; Jörg Pont; Lothar Kanz; Craig Nichols; Lawrence Einhorn
Extragonadal germ cell tumors: relation to testicular neoplasia and management options.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2003;111(1):49-59; discussion 59-63.
2003: Catherine Terret; Sylvain Gaujard; Jean Pierre Droz
[Current views in geriatric oncology].
Bulletin du cancer 2003;90(1):93-6.
2002: Thomas Bachelot; Frédéric Gomez; Pierre Biron; ISABELLE RAY COQUARD; P Soler-Michel; Irène Philip; Jean-Paul Guastalla; Paul Rebattu; Arlette Dumortier; Jean Pierre Droz; Jean-Yves Blay
A phase I/II study of 4 monthly courses of high-dose cyclophosphamide and thiotepa for metastatic breast cancer patients.
British journal of cancer 2002;87(10):1079-85.
2002: Aude Flechon; Emmanuelle Bompas; Pierre Biron; Jean Pierre Droz
Management of post-chemotherapy residual masses in advanced seminoma.
The Journal of urology 2002;168(5):1975-9.
2002: Emmanuelle Bompas; Aude Fléchon; Pierre Biron; Jean Pierre Droz
[Management of advanced seminoma: retrospective study of 96 patients].
Bulletin du cancer 2002;89(10):877-85.
2002: Charlotte van Kesteren; Ron A A Mathôt; Eric Raymond; Jean-Pierre Armand; Christian Dittrich; Herlinde Dumez; Henri Roché; Jean Pierre Droz; Cornelis J A Punt; Miroslav Ravic; Jantien Wanders; Jos H Beijnen; Pierre Fumoleau; J H M Schellens
Population pharmacokinetics of the novel anticancer agent E7070 during four phase I studies: model building and validation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(19):4065-73.
2002: Christine Clippe; Sébastien Clippe; Delphine Yzebe; Aude Flechon; Jean Pierre Droz
[Bladder cancer chemotherapy practice study].
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie 2002;12(4):609-14.
2002: Bernard Escudier; Jean Pierre Droz; Frédéric Rolland; M J Terrier-Lacombe; G Gravis; Philippe Beuzeboc; B Chauvet; Christine Chevreau; Jean-Christophe Eymard; Thierry Lesimple; Yacine Merrouche; Stéphane Oudard; Frank Priou; C Guillemare; Sophie Gourgou; Stéphane Culine
Doxorubicin and ifosfamide in patients with metastatic sarcomatoid renal cell carcinoma: a phase II study of the Genitourinary Group of the French Federation of Cancer Centers.
The Journal of urology 2002;168(3):959-61.
2002: Jörg Thomas Hartmann; Craig Nichols; Jean Pierre Droz; Alan Horwich; Arthur Gerl; Sophie D Fossa; Jörg Beyer; Jörg Pont; Lothar Kanz; Lawrence Einhorn; Carsten Bokemeyer
Prognostic variables for response and outcome in patients with extragonadal germ-cell tumors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(7):1017-28.
2002: Carsten Bokemeyer; Craig Nichols; Jean Pierre Droz; Hans-J Schmoll; Alan Horwich; Arthur Gerl; Sophie D Fossa; Jörg Beyer; Jörg Pont; Lothar Kanz; Lawrence Einhorn; Jörg Thomas Hartmann
Extragonadal germ cell tumors of the mediastinum and retroperitoneum: results from an international analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(7):1864-73.
2002: Jean Pierre Droz; Aude Flechon; Catherine Lombard-Bohas
[Chemotherapy of neuroendocrine tumors].
La Revue du praticien 2002;52(3):285-9.
2002: Jean Pierre Droz; A Fléchon; C Terret
Prostate cancer: management of advanced disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13 Suppl 4():89-94.
2001: Mojgan Devouassoux-Shisheboran; Claire Mauduit; Raymonde Bouvier; F Berger; M Bouras; Jean Pierre Droz; Mohamed Benahmed
Expression of hMLH1 and hMSH2 and assessment of microsatellite instability in testicular and mediastinal germ cell tumours.
Molecular human reproduction 2001;7(12):1099-105.
2001: Jörg Thomas Hartmann; Sophie D Fossa; Craig Nichols; Jean Pierre Droz; Alan Horwich; Arthur Gerl; Jörg Beyer; Jörg Pont; Karim Fizazi; H Hecker; Lothar Kanz; Lawrence Einhorn; Carsten Bokemeyer
Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors.
Journal of the National Cancer Institute 2001;93(22):1733-8.
2001: Karim Fizazi; R J Amato; P Beuzeboc; N Petit; D Bouhour; A Thiss; Christine Rebischung; Christine Chevreau; Christopher J Logothetis; Jean Pierre Droz
Germ cell tumors in patients infected by the human immunodeficiency virus.
Cancer 2001;92(6):1460-7.
2001: jean leon lagrange; Alain Ramaioli; Christine Theodore; Marie-José Terrier-Lacombe; Véronique Beckendorf; Pierre Biron; Christine Chevreau; P Chinet-Charrot; J Dumont; A Delobel-Deroide; Joëlle d'Anjou; C Chassagne; R M Parache; J M Karsenty; J Mercier; Jean Pierre Droz
Non-Hodgkin's lymphoma of the testis: a retrospective study of 84 patients treated in the French anticancer centres.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(9):1313-9.
2001: Aude Fléchon; Michel Rivoire; Pierre Biron; Jean Pierre Droz
Importance of surgery as salvage treatment after high dose chemotherapy failure in germ cell tumors.
The Journal of urology 2001;165(6 Pt 1):1920-6.
2001: Karim Fizazi; S Tjulandin; Roberto Salvioni; Josep Ramón Germà-Lluch; Jeannine Bouzy; D Ragan; Carsten Bokemeyer; Arthur Gerl; Aude Fléchon; J S de Bono; Sally P Stenning; Alan Horwich; Jörg Pont; P Albers; Ugo De Giorgi; mark bower; A Bulanov; Giorgio Pizzocaro; Jorge Aparicio; Craig Nichols; Christine Théodore; Jörg Thomas Hartmann; Hans-J Schmoll; S B Kaye; Stéphane Culine; Jean Pierre Droz; Cédric Mahé
Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an international study group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(10):2647-57.
2001: Carsten Bokemeyer; Jean Pierre Droz; Alan Horwich; Arthur Gerl; Sophie D Fossa; Jörg Beyer; Jörg Pont; Hans-J Schmoll; Lothar Kanz; Lawrence Einhorn; Craig Nichols; Jörg Thomas Hartmann
Extragonadal seminoma: an international multicenter analysis of prognostic factors and long term treatment outcome.
Cancer 2001;91(7):1394-401.
2001: Jörg Thomas Hartmann; Lawrence Einhorn; Craig Nichols; Jean Pierre Droz; Alan Horwich; Arthur Gerl; Sophie D Fossa; Jörg Beyer; Jörg Pont; Hans-J Schmoll; Lothar Kanz; Carsten Bokemeyer
Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: results of an international multicenter analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(6):1641-8.
2001: J Alexandre; Karim Fizazi; Cédric Mahé; Stéphane Culine; Jean Pierre Droz; Christine Théodore; Marie-José Terrier-Lacombe
Stage I non-seminomatous germ-cell tumours of the testis: identification of a subgroup of patients with a very low risk of relapse.
European journal of cancer (Oxford, England : 1990) 2001;37(5):576-82.
2001: N Baou; M Bouras; Jean Pierre Droz; N Dutrieux-Berger; Raymonde Bouvier; Mohamed Benahmed; Slavica Krantic
Somatostatin receptor expression profile as a potential criterion for discrimination between seminoma and non-seminoma testicular tumors.
Cancer detection and prevention 2001;25(5):446-53.
2001: Aude Fléchon; Stéphane Culine; Jean Pierre Droz
Intensive and timely chemotherapy, the key of success in testicular cancer.
Critical reviews in oncology/hematology 2001;37(1):35-46.
2000: F Andre; Karim Fizazi; Stéphane Culine; Jean Pierre Droz; Michel Gatineau; Y Takahashi; Stéphane Oudard; Christine Theodore
Peritoneal carcinomatosis in germ-cell tumor: relations with retroperitoneal lymph node dissection.
American journal of clinical oncology 2000;23(5):460-2.
2000: F André; Karim Fizazi; Stéphane Culine; Jean Pierre Droz; P Taupin; Catherine Lhommé; Marie-José Terrier-Lacombe; Christine Théodore
The growing teratoma syndrome: results of therapy and long-term follow-up of 33 patients.
European journal of cancer (Oxford, England : 1990) 2000;36(11):1389-94.
2000: Jörg Thomas Hartmann; Craig Nichols; Jean Pierre Droz; Alan Horwich; Arthur Gerl; Sophie D Fossa; Jörg Beyer; Jörg Pont; Lawrence Einhorn; Lothar Kanz; Carsten Bokemeyer
The relative risk of second nongerminal malignancies in patients with extragonadal germ cell tumors.
Cancer 2000;88(11):2629-35.
2000: N Baou; M Bouras; Jean Pierre Droz; Mohamed Benahmed; Slavica Krantic
Evidence for a selective loss of somatostatin receptor subtype expression in male germ cell tumors of seminoma type.
Carcinogenesis 2000;21(4):805-10.
2000: M Bouras; Eric Tabone; J Bertholon; P Sommer; Raymonde Bouvier; Jean Pierre Droz; Mohamed Benahmed
A novel SMAD4 gene mutation in seminoma germ cell tumors.
Cancer research 2000;60(4):922-8.
2000: Thomas Bachelot; ISABELLE RAY COQUARD; Gilles Catimel; Claude Ardiet; Jean-Paul Guastalla; Arlette Dumortier; Franck Chauvin; Jean Pierre Droz; Thierry Philip; MD Clavel
Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trials.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(2):151-6.
2000: Jörg Thomas Hartmann; Craig Nichols; Jean Pierre Droz; Alan Horwich; Arthur Gerl; Sophie D Fossa; Jörg Beyer; Jörg Pont; Karim Fizazi; Lawrence Einhorn; Lothar Kanz; Carsten Bokemeyer
Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors.
Journal of the National Cancer Institute 2000;92(1):54-61.
2000: Aude Fléchon; Jean Pierre Droz
[Germ cell tumors of the testes: state of the art].
Cancer radiothérapie : journal de la Société française de radiothérapie oncologique 2000;4(1):27-31.
1999: Aude Fléchon; Pierre Biron; Jean Pierre Droz
High-dose chemotherapy with hematopoietic stem-cell support in germ-cell tumor patient treatment: the French experience.
International journal of cancer. Journal international du cancer 1999;83(6):844-7.
1999: Aude Fléchon; Pierre Biron; I Philip; J Y Blay; Jean Pierre Droz
[High dose chemotherapy with autologous stem cell support in the treatment of germ cell tumors: experience of the centre Léon-Bérard between 1982 and 1996].
Bulletin du cancer 1999;86(4):391-9.
1999: Claude Ardiet; Brigitte Tranchand; S Zanetta; A Guillot; E Bernard; M Peguy; Paul Rebattu; Jean Pierre Droz
A sensitive docetaxel assay in plasma by solid-phase extraction and high performance liquid chromatography-UV detection: validation and suitability in phase I clinical trial pharmacokinetics.
Investigational new drugs 1999;17(4):325-33.
1999: Stéphane Culine; Andrew Kramar; Jean Pierre Droz; Christine Théodore
Phase II study of all-trans retinoic acid administered intermittently for hormone refractory prostate cancer.
The Journal of urology 1999;161(1):173-5.
1998: Stéphane Culine; M Bekradda; A Kramar; Annie Rey; Bernard Escudier; Jean Pierre Droz
Prognostic factors for survival in patients with brain metastases from renal cell carcinoma.
Cancer 1998;83(12):2548-53.
1998: Stéphane Culine; J Kattan; S Zanetta; Christine Théodore; Karim Fizazi; Jean Pierre Droz
Evaluation of estramustine phosphate combined with weekly doxorubicin in patients with androgen-independent prostate cancer.
American journal of clinical oncology 1998;21(5):470-4.
1998: Christian Kollmannsberger; Jörg Beyer; Jean Pierre Droz; Andreas Harstrick; Jörg Thomas Hartmann; Pierre Biron; Aude Fléchon; Patrick Schöffski; Markus Kuczyk; Hans-J Schmoll; Lothar Kanz; Carsten Bokemeyer
Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(10):3386-91.
1998: Stéphane Culine; L Abs; Marie-José Terrier-Lacombe; Christine Théodore; Pierre Wibault; Jean Pierre Droz
Cisplatin-based chemotherapy in advanced seminoma: the Institut Gustave Roussy experience.
European journal of cancer (Oxford, England : 1990) 1998;34(3):353-8.
1998: Karim Fizazi; Stéphane Culine; Jean Pierre Droz; Marie-José Terrier-Lacombe; Christine Théodore; Pierre Wibault; O Rixe; Pierre Ruffié; Thierry Le Chevalier
Initial management of primary mediastinal seminoma: radiotherapy or cisplatin-based chemotherapy?
European journal of cancer (Oxford, England : 1990) 1998;34(3):347-52.
1998: Karim Fizazi; Stéphane Culine; Jean Pierre Droz; Andrew Kramar; Christine Théodore; Pierre Ruffié; Thierry Le Chevalier
Primary mediastinal nonseminomatous germ cell tumors: results of modern therapy including cisplatin-based chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(2):725-32.
1998: ISABELLE RAY COQUARD; Pierre Biron; Thomas Bachelot; Jean-Paul Guastalla; Gilles Catimel; Yacine Merrouche; Jean Pierre Droz; Franck Chauvin; Jean-Yves Blay
Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimens.
Cancer 1998;82(1):134-40.
1997: Stéphane Culine; I Philippot; fadi farhat; Christine Théodore; Marie-José Terrier-Lacombe; Jean Pierre Droz
Evaluation of long-term results of a modified VAB-6 chemotherapy regimen in a cohort of good-risk metastatic non seminomatous germ-cell tumors.
Bulletin du cancer 1997;84(4):368-72.
1997: Stéphane Culine; Christine Théodore; M Bekradda; fadi farhat; Marie-José Terrier-Lacombe; Jean Pierre Droz
Experience with bleomycin, etoposide, cisplatin (BEP) and alternating cisplatin, cyclophosphamide, doxorubicin (CISCA(II))/vinblastine, bleomycin (VB(IV)) regimens of chemotherapy in poor-risk nonseminomatous germ cell tumors.
American journal of clinical oncology 1997;20(2):184-8.
1997: Karim Fizazi; Stéphane Culine; Jean Pierre Droz; Thierry Le Chevalier; Pierre Ruffié; Christine Théodore
[Primary mediastinal non-seminomatous germ-cell tumors: from clinics to biology].
Bulletin du cancer 1997;84(3):313-27.
1997: Stéphane Culine; Christine Theodore; Marie-José Terrier-Lacombe; Jean Pierre Droz
Are 3 cycles of bleomycin, etoposide and cisplatin or 4 cycles of etoposide and cisplatin equivalent optimal regimens for patients with good risk metastatic germ cell tumors of the testis? The need for a randomized trial.
The Journal of urology 1997;157(3):855-8; discussion 858-9.
1997: Stéphane Culine; Christine Theodore; Bernard Court; JL Perrin; Jean Pierre Droz
Evaluation of primary standard cisplatin-based chemotherapy for clinical stage II non-seminomatous germ cell tumours of the testis.
British journal of urology 1997;79(2):258-62.
1997: Stéphane Culine; Catherine Lhomme; J Kattan; G Michel; Pierre Duvillard; Jean Pierre Droz
Cisplatin-based chemotherapy in the management of germ cell tumors of the ovary: The Institut Gustave Roussy Experience.
Gynecologic oncology 1997;64(1):160-5.
1996: Stéphane Culine; Catherine Lhomme; G Michel; J Leclere; Pierre Duvillard; Jean Pierre Droz
Is there a role for second-look laparotomy in the management of malignant germ cell tumors of the ovary? Experience at Institut Gustave Roussy.
Journal of surgical oncology 1996;62(1):40-5.
1996: Stéphane Culine; Christine Theodore; Marie-José Terrier-Lacombe; Jean Pierre Droz
Primary chemotherapy in patients with nonseminomatous germ cell tumors of the testis and biological disease only after orchiectomy.
The Journal of urology 1996;155(4):1296-8.
1996: fadi farhat; Stéphane Culine; Catherine Lhommé; Pierre Duvillard; Patrick Soulié; G Michel; Marie-José Terrier-Lacombe; Christine Théodore; M Schreinerova; Jean Pierre Droz
Desmoplastic small round cell tumors: results of a four-drug chemotherapy regimen in five adult patients.
Cancer 1996;77(7):1363-6.
1996: fadi farhat; Stéphane Culine; Christine Théodore; M Békradda; Marie-José Terrier-Lacombe; Jean Pierre Droz
Cisplatin and ifosfamide with either vinblastine or etoposide as salvage therapy for refractory or relapsing germ cell tumor patients: the Institut Gustave Roussy experience.
Cancer 1996;77(6):1193-7.
1996: Stéphane Culine; Christine Theodore; fadi farhat; M Bekradda; Marie-José Terrier-Lacombe; Jean Pierre Droz
Cisplatin-based chemotherapy after retroperitoneal lymph node dissection in patients with pathological stage II nonseminomatous germ cell tumors.
Journal of surgical oncology 1996;61(3):195-8.
1995: Stéphane Culine; C Lhomme; fadi farhat; Jean Pierre Droz
Salvage chemotherapy in non-dysgerminomatous germ cell tumours of the ovary.
European journal of cancer (Oxford, England : 1990) 1995;31A(11):1890-1.
1995: Stéphane Culine; Christine Theodore; M J Terrier-Lacombe; Jean Pierre Droz
Chemotherapy in stage II nonseminomatous germ cell tumors of the testis: The institut Gustave roussy experience.
Urologic oncology 1995;1(5):175-83.
1995: Stéphane Culine; Catherine Lhomme; Joseph Kattan; Pierre Duvillard; G Michel; Alain Gerbaulet; Jean Pierre Droz
Cisplatin-based chemotherapy in dysgerminoma of the ovary: thirteen-year experience at the Institut Gustave Roussy.
Gynecologic oncology 1995;58(3):344-8.
1995: fadi farhat; Stéphane Culine; C Lhomme; Pierre Duvillard; Marie-José Terrier-Lacombe; G Michel; P Soulie; Christine Theodore; J P Lotz; Jean Pierre Droz
[Desmoplastic small round cell tumors in adults: a new entity].
Bulletin du cancer 1995;82(8):665-73.
1995: L Mounedji-Boudiaf; Philippe Rougier; Stéphane Culine; Thierry de Baere; Philippe Lasser; Bernard Escudier; Michel Ducreux; E Kaloustian; Jean Pierre Droz; A Roche
[Treatment of metastatic malignant insulinomas. 2 cases].
Presse médicale (Paris, France : 1983) 1995;24(19):894-6.
1995: Stéphane Culine; Jean Pierre Droz; R Delva; B Bui; Armelle Caty; B Minier; P Mital; M Mousseau
Rapidly recycled, intensive alternating chemotherapy in heavily pretreated progressive nonseminomatous germ cell tumors a feasibility study.
Urologic oncology 1995;1(3):109-14.
1995: Anne-Marie Vénuat; Jean Pierre Droz; Marie-José Terrier-Lacombe; C Machavoine; Alain BERNHEIM
Cytogenetic study of a case of synchronous bilateral seminoma.
Cancer genetics and cytogenetics 1995;81(1):17-9.
1995: fadi farhat; Stéphane Culine; Marie-José Terrier-Lacombe; Jean Pierre Droz
[Adenocarcinoma of rete testis. Apropos of a case and review of the literature].
Bulletin du cancer 1995;82(2):167-72.
1995: M Ostronoff; C Soussain; E Zambon; A Moran; Jean Pierre Droz; Jacques Bosq; Chantal Bayle; Jean-Marc Cosset; M Hayat
Localized stage non-Hodgkin's lymphoma of the testis: a retrospective study of 16 cases.
Nouvelle revue française d'hématologie 1995;37(5):267-72.
1995: Stéphane Culine; M Bekradda; Marie-José Terrier-Lacombe; Jean Pierre Droz
Treatment of sarcomatoid renal cell carcinoma: is there a role for chemotherapy?
European urology 1995;27(2):138-41.
1995: Joseph Kattan; Stéphane Culine; Christine Theodore; Jean Pierre Droz
Phase II trial of ifosfamide, fluorouracil, and folinic acid (FIFO regimen) in relapsed and refractory urothelial cancer.
Cancer investigation 1995;13(3):276-9.
1995: José-Luis Pico; E Fadel; A Ibrahim; J H Bourhis; Jean Pierre Droz
High-dose chemotherapy followed by hematological support: experience in the treatment of germ cell tumors.
Bulletin du cancer 1995;82 Suppl 1():56s-60s.
1994: Joseph Kattan; A Spatz; Stéphane Culine; Marie-José Terrier-Lacombe; Dominique Elias; Jean Pierre Droz
Hepatocellular carcinoma during hormonotherapy for prostatic cancer.
American journal of clinical oncology 1994;17(5):390-2.
1994: L Abs; Joseph Kattan; Stéphane Culine; M Bekradda; fadi farhat; Jean Pierre Droz
[Value of mono-antibiotic therapy using piperacillin associated with sulbactam and possibly followed by vancomycin in febrile neutropenia in solid tumors].
Bulletin du cancer 1994;81(10):871-6.
1994: A Moran-Ribon; Jean Pierre Droz; Joseph Kattan; B Leclercq; Marwan Ghosn; D Couanet; M Ostronoff; Stéphane Culine; B Misset; Bernard Escudier
Super-high-risk germ-cell tumors: a clinical entity. Report of eleven cases.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1994;2(4):253-8.
1994: Stéphane Culine; Joseph Kattan; Catherine Lhomme; Pierre Duvillard; G Michel; Damienne Castaigne; J Leclere; J Pico; Jean Pierre Droz
A phase II study of high-dose cisplatin, vinblastine, bleomycin, and etoposide (PVeBV regimen) in malignant nondysgerminomatous germ-cell tumors of the ovary.
Gynecologic oncology 1994;54(1):47-53.
1994: Joseph Kattan; M Durand; Jean Pierre Droz; Mondher Mahjoubi; J P Marino; M Azab
Phase I study of retelliptine dihydrochloride (SR 95325 B) using a single two-hour intravenous infusion schedule.
American journal of clinical oncology 1994;17(3):242-5.
1994: L Mounedji-Boudiaf; Stéphane Culine; G Devoldère; Marie-José Terrier-Lacombe; Joseph Kattan; A Cazier; FADI SAMI FARHAT; M Bekradda; Jean Pierre Droz
[Primary, highly malignant B-cell lymphoma of the prostate. Apropos of a case and review of the literature].
Bulletin du cancer 1994;81(4):334-7.
1994: Stéphane Culine; Marie-José Terrier-Lacombe; Joseph Kattan; Jean Pierre Droz
[Carcinoma in situ of the testis].
Bulletin du cancer 1994;81(4):318-25.
1994: Y Chraibi; Stéphane Culine; Marie-José Terrier-Lacombe; Andrew Kramar; Joseph Kattan; Jean Pierre Droz
[Prognostic factors for extratesticular involvement in stage I testicular cancer. Apropos of 58 cases].
Bulletin du cancer 1994;81(4):311-7.
1994: fadi farhat; Joseph Kattan; Stéphane Culine; Christine Théodore; Marie-José Terrier-Lacombe; J Génin; L Mounedji-Boudiaf; M Bekradda; Jean Pierre Droz
[Liposarcoma of the spermatic cord: apropos of a case with review of the literature].
Bulletin du cancer 1994;81(3):223-5.
1994: Joseph Kattan; Stéphane Culine; T Tavakoli-Razavi; Andrew Kramar; Jean Pierre Droz
Acute tumor lysis syndrome in poor-risk germ cell tumors: does it exist?
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1994;2(2):128-31.
1994: Joseph Kattan; Jean Pierre Droz; Stéphane Culine; B Escudier; C Beaumont-Raymond
Recombinant interferon-alpha efficacy in relapsed adult nephroblastoma: a case report.
The Journal of urology 1994;151(2):411-2.
1994: fadi farhat; Joseph Kattan; Stéphane Culine; M Bekradda; Jean Pierre Droz
[Efficacy of the combination of 5 fluorouracil, adriamycin and cisplatin (FAP protocol) in the treatment of metastatic cylindroma. Apropos of a case with review of the literature].
Bulletin du cancer 1994;81(1):47-50.
1994: Joseph Kattan; MF Tournade; Stéphane Culine; Marie-José Terrier-Lacombe; Jean Pierre Droz
Adult Wilms' tumour: review of 22 cases.
European journal of cancer (Oxford, England : 1990) 1994;30A(12):1778-82.
1994: Stéphane Culine; Catherine Lhomme; Joseph Kattan; Pierre Duvillard; G Michel; Jean Pierre Droz
Long-term results of two VAB-like regimens (vinblastine + actinomycin-D + bleomycin + cyclophosphamide + cisplatin) in malignant germ cell tumours of the ovary.
European journal of cancer (Oxford, England : 1990) 1994;30A(9):1239-44.
1994: Jean Pierre Droz; E De Smedt; Joseph Kattan; F Keuppens; S Khoury; C Mahler; L Denis
Phase I trial of high-dose fosfestrol in hormone-refractory adenocarcinoma of the prostate.
The Prostate 1994;24(2):62-6.
1993: Joseph Kattan; Stéphane Culine; Marie-José Terrier-Lacombe; Christine Théodore; Jean Pierre Droz
Paratesticular rhabdomyosarcoma in adult patients: 16-year experience at Institut Gustave-Roussy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(10):871-5.
1993: José-Luis Pico; A Ibrahim; L Castagna; J H Bourhis; M Chazard; D Maraninchi; Jean Pierre Droz
Escalating high-dose carboplatin and autologous bone marrow transplantation in solid tumors.
Oncology 1993;50 Suppl 2():47-52.
1993: Mondher Mahjoubi; Joseph Kattan; Marc Bonnay; H Schmitt; Jean Pierre Droz
Phase II trial of LY 186641 in advanced renal cancer.
Investigational new drugs 1993;11(4):323-8.
1993: Joseph Kattan; Stéphane Culine; Jean Pierre Droz; E Fadel; Bernard Court; J L Perrin; Pierre Wibault; Christine Haie-Meder
Penile cancer chemotherapy: twelve years' experience at Institut Gustave-Roussy.
Urology 1993;42(5):559-62.
1993: S Giacchetti; Y Raoul; Pierre Wibault; Jean Pierre Droz; Bernard Court; François Eschwege
Treatment of stage I testis seminoma by radiotherapy: long-term results--a 30-year experience.
International journal of radiation oncology, biology, physics 1993;27(1):3-9.
1993: Joseph Kattan; Jean Pierre Droz; Stéphane Culine; Pierre Duvillard; A Thiellet; C Peillon
The growing teratoma syndrome: a woman with nonseminomatous germ cell tumor of the ovary.
Gynecologic oncology 1993;49(3):395-9.
1993: I Marcillac; P Cottu; C Théodore; M J Terrier-Lacombe; Dominique Bellet; Jean Pierre Droz
Free hCG-beta subunit as tumour marker in urothelial cancer.
Lancet 1993;341(8856):1354-5.
1993: Philippe Rougier; J J Zarba; Michel Ducreux; M Basile; Jean-Pierre Pignon; Mondher Mahjoubi; M Benahmed; Jean Pierre Droz; Esteban Cvitkovic; Jean-Pierre Armand
Phase II study of cisplatin and 120-hour continuous infusion of 5-fluorouracil in patients with advanced pancreatic adenocarcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(4):333-6.
1993: J Douchez; Jean Pierre Droz; B Desclaux; Y Allain; Pierre Fargeot; Armelle Caty; P Charrot
Quality of life in long-term survivors of nonseminomatous germ cell testicular tumors.
The Journal of urology 1993;149(3):498-501.
1993: Joseph Kattan; Jean Pierre Droz; Stéphane Culine
[High dose fosfestrol in phase I-II trial for the treatment of hormone-resistant prostatic adenocarcinoma].
Bulletin du cancer 1993;80(3):248-54.
1993: Jean Pierre Droz; Joseph Kattan; Marc Bonnay; Y Chraibi; M Bekradda; Stéphane Culine
High-dose continuous-infusion fosfestrol in hormone-resistant prostate cancer.
Cancer 1993;71(3 Suppl):1123-30.
1993: Jean Pierre Droz; José-Luis Pico; Andrew Kramar
Role of autologous bone marrow transplantation in germ-cell cancer.
The Urologic clinics of North America 1993;20(1):161-71.
1993: Mondher Mahjoubi; Joseph Kattan; Jean Pierre Droz; I Philippot; P Pautier; A Boutan-Laroze; M Azab; Christine Theodore
Feasibility trial of a combination of vinorelbine, ifosfamide, fluorouracil and folinic acid (VIF regimen) in advanced urothelial cancer.
European journal of cancer (Oxford, England : 1990) 1993;29A(2):285-6.
1993: Jean Pierre Droz; A T van Oosterom
Treatment options in clinical stage I non-seminomatous germ cell tumours of the testis: a wager on the future? A review.
European journal of cancer (Oxford, England : 1990) 1993;29A(7):1038-44.
1993: Jean Pierre Droz; Andrew Kramar; José-Luis Pico
Prediction of long-term response after high-dose chemotherapy with autologous bone marrow transplantation in the salvage treatment of non-seminomatous germ cell tumours.
European journal of cancer (Oxford, England : 1990) 1993;29A(6):818-21.
1993: Andrew Kramar; Jean Pierre Droz; Annie Rey; Jeannine Bouzy; I Philippot; Stéphane Culine
Prognostic factors in non-seminomatous germ cell tumours of the testis. Experience at the Institut Gustave-Roussy.
European urology 1993;23(1):188-95.
1993: Joseph Kattan; Mondher Mahjoubi; Jean Pierre Droz; Andrew Kramar; Stéphane Culine; A Boutan-Laroze; M Chazard
High failure rate of carboplatin-etoposide combination in good risk non-seminomatous germ cell tumours.
European journal of cancer (Oxford, England : 1990) 1993;29A(11):1504-9.
1993: Jean Pierre Droz; Christine Théodore
[Use of G-CSF in chemotherapy of urogenital cancers].
Pathologie-biologie 1993;41(1):48-9.
1992: Mondher Mahjoubi; Joseph Kattan; Marwan Ghosn; Jean Pierre Droz; I Philippot; P Herait
Phase II trial of pirarubicin in the treatment of advanced bladder cancer.
Investigational new drugs 1992;10(4):317-21.
1992: Jean-Michel Bidart; Frédéric Troalen; Vladimir Lazar; P Berger; I Marcillac; Catherine Lhomme; Jean Pierre Droz; Dominique Bellet
Monoclonal antibodies to the free beta-subunit of human chorionic gonadotropin define three distinct antigenic domains and distinguish between intact and nicked molecules.
Endocrinology 1992;131(4):1832-40.
1992: Joseph Kattan; Jean Pierre Droz; P Couvreur; J P Marino; A Boutan-Laroze; Philippe Rougier; Philippe Brault; H Vranckx; JM Grognet; X Morge
Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles.
Investigational new drugs 1992;10(3):191-9.
1992: I Marcillac; Frédéric Troalen; Jean-Michel Bidart; P Ghillani; V Ribrag; B Escudier; B Malassagne; Jean Pierre Droz; C Lhommé; Philippe Rougier
Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasms.
Cancer research 1992;52(14):3901-7.
1992: Joseph Kattan; Jean Pierre Droz; P Charpentier; G Michel; Catherine Lhommé; A Boutan-Laroze; M Prade
Ovarian dysgerminoma metastatic to the breast.
Gynecologic oncology 1992;46(1):104-6.
1992: Jean Pierre Droz; Andrew Kramar; Pierre Wibault; J J Perrin; Alain Roche; Bernard Escudier; Gilles Missenard; Bernard Court
[Therapeutic strategy in metastatic renal cancer].
La Revue du praticien 1992;42(10):1253-7.
1992: Jean Pierre Droz; Andrew Kramar; Annie Rey
Prognostic factors in metastatic disease.
Seminars in oncology 1992;19(2):181-9.
1992: Jean Pierre Droz; Catherine Lhommé
[Gestational trophoblastic tumors].
La Revue du praticien 1992;42(7):817-22.
1992: Jean Pierre Droz; Pierre Ruffié
[Germinal tumors of the mediastinum. Therapeutic strategy, prognosis, biology].
Revue des maladies respiratoires 1992;9(3):251-4.
1992: Pierre Ruffié; Jean Pierre Droz
[Mediastinal seminoma. Is it an entity to be treated differently?].
Revue des maladies respiratoires 1992;9(3):245-9.
1992: Joseph Kattan; Jean Pierre Droz; Vincent Ribrag; M Azab; A Boutan-Laroze; Antoine Andremont
Non-nephrotoxic empiric antimicrobial therapy in febrile neutropenic cancer patients.
European journal of cancer (Oxford, England : 1990) 1992;28A(4-5):867-70.
1992: Joseph Kattan; Jean Pierre Droz; Stéphane Culine; Vincent Ribrag; A Boutan-Laroze; Antoine Andremont
[Value of the combination of piperacillin and pefloxacin possibly followed by vancomycin in the treatment of febrile neutropenia in nephrotoxic chemotherapy].
Bulletin du cancer 1992;79(7):705-12.
1992: Jean Pierre Droz; José-Luis Pico; Marwan Ghosn; Andrew Kramar; A Rey; M Ostronoff; D Baume
A phase II trial of early intensive chemotherapy with autologous bone marrow transplantation in the treatment of poor prognosis non seminomatous germ cell tumors.
Bulletin du cancer 1992;79(5):497-507.
1992: Jean Pierre Droz
[Report of the ASCO and AACR II congress, San Diego, 17-23 May 1992. Plenary session and urologic oncology sessions].
Bulletin du cancer 1992;79(9):909-15.
1992: Jean Pierre Droz; Jean-Marc Cosset
[Go France ... ASCO/AACR congress, San Diego I, 17-23 May 1992].
Bulletin du cancer 1992;79(9):829-35.
1992: Vincent Ribrag; Jean Pierre Droz; Joseph Kattan; Antoine Andremont
Infectious complications associated with granulocytopenia during the treatment of poor risk or relapsed germ cell tumors.
Bulletin du cancer 1992;79(5):491-5.
1992: M Ostronoff; C Soussain; E Zambon; A Ibrahim; Jacques Bosq; Chantal Bayle; José-Luis Pico; Erard Gilles; A Moran; Jean Pierre Droz
Burkitt's lymphoma in adults: a retrospective study of 46 cases.
Nouvelle revue française d'hématologie 1992;34(5):389-97.
1992: C Soussain; P Michel-Langlet; Mondher Mahjoubi; Marie-José Terrier-Lacombe; Jean Pierre Droz
[Brain metastasis of choriocarcinoma in males. Apropos of a case. Review of the literature].
Bulletin du cancer 1992;79(8):751-7.
1991: Martin Schlumberger; L Brugieres; C Gicquel; Jean-Paul Travagli; Jean Pierre Droz; Claude Parmentier
5-Fluorouracil, doxorubicin, and cisplatin as treatment for adrenal cortical carcinoma.
Cancer 1991;67(12):2997-3000.
1991: Joseph Kattan; Jean Pierre Droz; A Boutan-Laroze; B Deforges; Marie-José Terrier-Lacombe; D Vanel; Antoine Lusinchi
[Choroid metastasis in a case of urothelial carcinoma metastatic from the bladder].
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie 1991;1(3):466-9.
1991: Martin Schlumberger; Claude Parmentier; M J Delisle; J E Couette; Jean Pierre Droz; D Sarrazin
Combination therapy for anaplastic giant cell thyroid carcinoma.
Cancer 1991;67(3):564-6.
1991: A Boutan-Laroze; Mondher Mahjoubi; Jean Pierre Droz; P Charrot; Pierre Fargeot; P Kerbrat; Armelle Caty; P M Voisin; Marc Spielmann; Annie Rey
M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced carcinoma of the bladder. The French Federation of Cancer Centers experience.
European journal of cancer (Oxford, England : 1990) 1991;27(12):1690-4.
1991: Stéphane Culine; Mondher Mahjoubi; I Philippot; Jean Pierre Droz
Treatment of good-risk disseminated non-seminomatous germ cell tumours: the less bleomycin, the more cisplatin?
European journal of cancer (Oxford, England : 1990) 1991;27(12):1715.
1991: Jean Pierre Droz; José-Luis Pico; Marwan Ghosn; Alain Gouyette; D Baume; G Piot; M Ostronoff; Christine Theodore; Françoise Beaujean; M Hayat
Long-term survivors after salvage high dose chemotherapy with bone marrow rescue in refractory germ cell cancer.
European journal of cancer (Oxford, England : 1990) 1991;27(7):831-5.
1991: Philippe Rougier; J Oliveira; Michel Ducreux; Christine Theodore; J Kac; Jean Pierre Droz
Metastatic carcinoid and islet cell tumours of the pancreas: a phase II trial of the efficacy of combination chemotherapy with 5-fluorouracil, doxorubicin and cisplatin.
European journal of cancer (Oxford, England : 1990) 1991;27(11):1380-2.
1990: Vincent Ribrag; Jean Pierre Droz; C Bouleuc; Christine Theodore; Marwan Ghosn; José-Luis Pico; M Azab; M Ostronoff; M Hayat
[Salvage chemotherapy of non-seminomatous germ cell tumors. Phase II trial of a combination of etoposide, ifosfamide and high-dose cisplatin].
Presse médicale (Paris, France : 1983) 1990;19(27):1263-6.
1990: Marie-José Terrier-Lacombe; F Martinez-Madrigal; W Porta; J Rahal; Jean Pierre Droz
Embryonal rhabdomyosarcoma arising in a mature teratoma of the testis: a case report.
The Journal of urology 1990;143(6):1232-4.
1990: Jean Pierre Droz; José-Luis Pico; Marwan Ghosn; M Ostronoff; M Azab; Christine Theodore; M Hayat
[Chemotherapeutic intensification in germ cell tumors].
Bulletin du cancer 1990;77(4):349-54.
1990: M Hayat; M Ostronoff; Erard Gilles; E Zambon; D Baume; A Moran; Patrice Carde; Jean Pierre Droz; José-Luis Pico
Salvage therapy with methyl-gag, high-dose Ara-C, M-Amsa, and ifosfamide (MAMI) for recurrent or refractory lymphoma.
Cancer investigation 1990;8(1):1-5.
1990: François Eschwege; Philippe Rougier; S Delanian; L Abensour; Jean Pierre Droz; Pierre Wibault; Antoine Lusinchi; Philippe Lasser
[Combination radiotherapy and chemotherapy in the treatment of locally advanced adenocarcinoma of the pancreas. Experiences of the Gustave Roussy Institute].
Bulletin du cancer 1990;77(3):245-9.
1990: J L Guimaraes; Marwan Ghosn; M Ostronoff; M Azab; Christine Theodore; Jean Pierre Droz
Phase II trial of methyl-gag and melphalan in metastatic adult renal cell carcinoma.
Cancer investigation 1990;8(6):623-4.
1990: Vincent Ribrag; M Ghnassia; Christine Théodore; Marwan Ghosn; G Piot; Daniel Beurton; J Cukier; Jean Pierre Droz
[Chemotherapy in advanced transitional cell carcinoma of the urinary tract. Phase II trial of a combination of doxorubicin and cisplatin].
Journal d'urologie 1990;96(7):373-4.
1990: Jean Pierre Droz; M B Azab; Christine Theodore; Marwan Ghosn; M Ostronoff; A Boutan-Laroze; Bernard Court; J L Perrin; Jean-Paul Travagli; Pierre Wibault
Phase II trial of pre- and postoperative cisplatin, methotrexate and vinblastine in infiltrating bladder cancer: a three year experience.
Progress in clinical and biological research 1990;353():137-42.
1990: Marwan Ghosn; M C Ha; F Pietri; C Garcin; Christine Théodore; Jean Pierre Droz
[Trial of premedication with lorazepam for the prevention of emetic effects of cisplatin].
Bulletin du cancer 1990;77(7):695-6.
1990: H Lupera; Jean Pierre Droz; Stéphane Culine; J L Perrin; Bernard Court; Marwan Ghosn; M Hayat
[Cancer of the bladder after treatment with cyclophosphamide. Apropos of a case and a review of the literature].
Journal d'urologie 1990;96(1):48-52.
1990: Jean Pierre Droz; P Ruffie; G Piot; Marwan Ghosn; J M Caillaud; D Elias; J L Perrin; P Levasseur
Sarcoidosis and testicular germ cell tumor. Case report.
Scandinavian journal of urology and nephrology 1990;24(3):171-3.
1990: D Baume; José-Luis Pico; Jean Pierre Droz; M Ostronoff; M Azab; Erard Gilles; Marwan Ghosn; E Salloum; Alain Gouyette; Françoise Beaujean
[Value of high-dose chemotherapy followed by bone marrow autograft in non-seminomatous germinal tumor with poor prognosis. Results of the combination of cisplatinum, etoposide and cyclophosphamide (PEC protocol)].
Bulletin du cancer 1990;77(2):169-80.
1990: Mondher Mahjoubi; M Azab; Marwan Ghosn; Christine Theodore; Jean Pierre Droz
Phase II trial of ifosfamide in the treatment of metastatic hormone-refractory patients with prostatic cancer.
Cancer investigation 1990;8(5):477-81.
1989: H Lupera; Christine Theodore; Marwan Ghosn; Bernard Court; Pierre Wibault; Jean Pierre Droz
Phase II trial of combination chemotherapy with dacarbazine, cyclophosphamide, cisplatin, doxorubicin, and vindesine (DECAV) in advanced renal cell cancer.
Urology 1989;34(5):281-3.
1989: Christine Theodore; M Azab; Jean Pierre Droz; A Assouline; M George; G Piot; Dominique Bellet; G Michel; J L Amiel
Treatment of high-risk gestational trophoblastic disease with chemotherapy combinations containing cisplatin and etoposide.
Cancer 1989;64(9):1824-8.
1989: M Azab; Jean Pierre Droz; Christine Theodore; J P Wolff; J L Amiel
Cisplatin, vinblastine, and bleomycin combination in the treatment of resistant high-risk gestational trophoblastic tumors.
Cancer 1989;64(9):1829-32.
1989: M B Azab; Michel Henry-Amar; Philippe Rougier; C Bognel; Christine Theodore; P Carde; P Lasser; J M Cosset; Bernard Caillou; Jean Pierre Droz
Prognostic factors in primary gastrointestinal non-Hodgkin's lymphoma. A multivariate analysis, report of 106 cases, and review of the literature.
Cancer 1989;64(6):1208-17.
1989: M Hayat; Jean Pierre Droz
[Medical treatment of advanced cancers of the breast (metastatic and at metastatic high-risk)].
Bulletin du cancer 1989;76(1):63-4.
1989: Philippe Rougier; J Oliveira; Michel Ducreux; Christine Theodore; M Azab; Jean Pierre Droz
[Efficacy of chemotherapy and combined chemo-radiotherapy in gastric adenocarcinoma].
Bulletin du cancer 1989;76(9):1007-20.
1989: François Eschwege; Y Raoul; Pierre Wibault; Jean Pierre Droz; Bernard Court; J L Perrin
Does radiotherapy still have a place in the treatment of bladder tumors?
Progress in clinical and biological research 1989;303():605-11.
1989: Stéphane Culine; M Azab; F Pietri; Marwan Ghosn; B Ben Amor; H Lupera; Christine Theodore; J Renaux; Jean Pierre Droz
[A phase III trial comparing the antiemetic activity of tetracosactide with dexamethasone in combination with metoclopramide, diphenhydramine and clorazepate during chemotherapy including cisplatin].
Bulletin du cancer 1989;76(6):583-9.
1989: C Louvet; J L Guimaraes; M Ostronoff; Christine Theodore; M Azab; B Leclercq; Jean Pierre Droz
[Paraneoplastic hypercalcemia and ovarian seminoma. Review of the literature and etiological discussion apropos of a case].
Bulletin du cancer 1989;76(4):347-52.
1989: M Azab; Christine Theodore; J Cukier; Daniel Beurton; Erard Gilles; Jean Pierre Droz
[Adjuvant chemotherapy using adriamycin and cisplatin in infiltrating cancer of the bladder. Prospective study of 49 cases].
Journal d'urologie 1989;95(8):459-63.
1989: H Lupera; Jean Pierre Droz; G Piot; P Lapleige; Pierre Fargeot; Christine Theodore
Phase II trial of combination chemotherapy with fluorouracil (F), doxorubicin (A), and cisplatin (P) (Fap) in hormonally resistant metastatic prostatic adenocarcinoma.
Oncology 1989;46(6):372-4.
1989: Jean Pierre Droz; Vincent Ribrag; Marwan Ghosn; J Guimares; Christine Theodore; M Azab; M Ostronoff; Mondher Mahjoubi; A Moran; J Pico
Phase II trial with etoposide (VP16) plus ifosfamide plus high-dose cisplatin (VIhP regimen) in refractory germ cell tumors.
Progress in clinical and biological research 1989;303():739-47.
1989: Philippe Rougier; Philippe Lasser; Dominique Elias; Marwan Ghosn; Michel Ducreux; Jean Lumbroso; S Sidibe; Jean Pierre Droz
Intra-arterial hepatic chemotherapy for metastatic liver from colo-rectal carcinoma origin.
Selective cancer therapeutics 1989;5(1):47-54.
1989: Y Raoul; Pierre Wibault; S Giacchetti; Bernard Court; B Perrin; J P Travagli; Jean Pierre Droz; François Eschwege
[Invasive tumors of the bladder. A study of 56 cases treated at the Gustave-Roussy Institute by total cystectomy and radiotherapy].
Annales d'urologie 1989;23(3):205-11.
1989: P Herait; Philippe Rougier; Christine Theodore; J Kac; Jean Pierre Droz
Alternating 5-FU-mitomycin C/5-FU-dacarbazine in advanced colorectal adenocarcinoma: a phase II study.
Oncology 1989;46(2):88-90.
1988: M B Azab; M H Pejovic; Christine Theodore; M George; Jean Pierre Droz; Dominique Bellet; G Michel; J L Amiel
Prognostic factors in gestational trophoblastic tumors. A multivariate analysis.
Cancer 1988;62(3):585-92.
1988: Jean Pierre Droz; Andrew Kramar; Marwan Ghosn; G Piot; Annie Rey; Christine Theodore; Pierre Wibault; Bernard Court; J L Perrin; Jean-Paul Travagli
Prognostic factors in advanced nonseminomatous testicular cancer. A multivariate logistic regression analysis.
Cancer 1988;62(3):564-8.
1988: Marwan Ghosn; Jean Pierre Droz; Christine Theodore; José-Luis Pico; D Baume; Marc Spielmann; M Ostronoff; A Moran; E Salloum; Andrew Kramar
Salvage chemotherapy in refractory germ cell tumors with etoposide (VP-16) plus ifosfamide plus high-dose cisplatin. A VIhP regimen.
Cancer 1988;62(1):24-7.
1988: Z Pastran; Thierry Le Chevalier; P Baldeyrou; Marc Spielmann; Rodrigo Arriagada; Jean Pierre Droz; J Rouesse
Phase II study of high dose ifosfamide plus mesna in inoperable non small cell lung carcinoma.
European journal of cancer & clinical oncology 1988;24(6):1073-4.
1988: Martin Schlumberger; M Ostronoff; M Bellaiche; Philippe Rougier; Jean Pierre Droz; Claude Parmentier
5-Fluorouracil, doxorubicin, and cisplatin regimen in adrenal cortical carcinoma.
Cancer 1988;61(8):1492-4.
1988: G Piot; Jean Pierre Droz; Christine Theodore; Marwan Ghosn; Jacques Rouëssé; J L Amiel
Phase II trial with high-dose elliptinium acetate in metastatic renal cell carcinoma.
Oncology 1988;45(5):371-2.
1988: Jean Pierre Droz; Christine Theodore; Marwan Ghosn; H Lupera; G Piot; A De Forges; M Klink; J Rouesse; J L Amiel
Twelve-year experience with chemotherapy in adult metastatic renal cell carcinoma at the Institut Gustave-Roussy.
Seminars in surgical oncology 1988;4(2):97-9.
1988: A de Forges; A Rey; M Klink; Marwan Ghosn; Andrew Kramar; Jean Pierre Droz
Prognostic factors of adult metastatic renal carcinoma: a multivariate analysis.
Seminars in surgical oncology 1988;4(3):149-54.
1988: Marwan Ghosn; Patrice Carde; B Leclerq; Françoise Flamant; S Friedman; Jean Pierre Droz; M Hayat
Ifosfamide/mesna related encephalopathy: a case report with a possible role of phenobarbital in enhancing neurotoxicity.
Bulletin du cancer 1988;75(4):391-2.
1988: Philippe Rougier; Marc Ychou; Jean Pierre Droz
[Failure of elliptinium acetate in the treatment of unresectable hepatocarcinoma (phase II trial)].
Bulletin du cancer 1988;75(10):979-81.
1987: Philippe Rougier; Jean Pierre Droz; Christine Theodore; G Piot; P Herait; P Ruffie; P Carde; Esteban Cvitkovic
Phase II trial of combined 5-fluorouracil plus doxorubicin plus cisplatin (FAP regimen) in advanced gastric carcinoma.
Cancer treatment reports 1987;71(12):1301-2.
1987: A De Forges; Jean Pierre Droz; Marwan Ghosn; Christine Theodore
Phase II trial of ifosfamide/mesna in metastatic adult renal carcinoma.
Cancer treatment reports 1987;71(11):1103.
1987: Philippe Rougier; Philippe Lasser; Jean Pierre Droz; Dominique Elias; Marwan Ghosn; Michel Ducreux; Jean Lumbroso; S Sidibe
[Locoregional chemotherapy of hepatic metastases of colorectal cancer].
Annales de gastroentérologie et d'hépatologie 1987;23(6):315-9.
1987: Alain Gouyette; A Deniel; José-Luis Pico; Jean Pierre Droz; D Baume; M Ostronoff; N le Bail; M Hayat
Clinical pharmacology of high-dose etoposide associated with cisplatin. Pharmacokinetic and metabolic studies.
European journal of cancer & clinical oncology 1987;23(11):1627-32.
1987: Jean Pierre Droz; Pierre Fargeot; P Laplaige; A Moran-Ribon; G Piot
Phase II trial of the association of doxorubicin, 5 FU and cis platinum in hormonally unresponsive metastatic carcinoma of the prostate.
Progress in clinical and biological research 1987;243B():235-42.
1986: P Lasser; D Elias; Philippe Rougier; G Piot; Jean Pierre Droz; J Lumbroso; J L Amiel
[Isolated hepatic metastases. Treatment by intra-arterial chemotherapy using a subcutaneous access chamber].
Presse médicale (Paris, France : 1983) 1986;15(6):237-40.
1985: G Piot; Jean Pierre Droz; Philippe Rougier; Christine Théodore; M Spielmann; P Carde; J L Amiel
[Treatment of hepatic metastases with unknown primary cancer].
Annales de gastroentérologie et d'hépatologie 1985;21(2):91-3.
1985: Philippe Rougier; G Piot; P Lasser; D Elias; Jean Pierre Droz; J Lumbroso; J L Amiel
[Locoregional chemotherapy of hepatic metastases].
Chirurgie; mémoires de l'Académie de chirurgie 1985;111(7):548-51.
1985: Jean Pierre Droz; G Piot; Christine Théodore; J L Amiel
[Chemosensitive metastatic cancer cured by surgery of the residual lesions].
Chirurgie; mémoires de l'Académie de chirurgie 1985;111(7):523-7.
1984: J L Amiel; Jean Pierre Droz; F Ben Ayed
[Choriogonadotrophic hormone and placental tumors].
Annales d'endocrinologie 1984;45(4-5):231-3.
1983: G Piot; Jean Pierre Droz; J M Caillaud; D Bellet; Pierre Wibault; G Brulé; J L Amiel
[Relapses of malignant nonseminomatous germinal testicular tumors].
Journal d'urologie 1983;89(1):49-51.
1982: A Gouyette; D Huertas; Jean Pierre Droz; J Rouesse; J L Amiel
Pharmacokinetics of 2-methyl-9-hydroxyellipticinium acetate (NSC-264137) in cancer patients (phase I study).
European journal of cancer & clinical oncology 1982;18(12):1285-92.
1982: F Ben Ayed; D Bellet; N Badri; M Spielmann; Jean Pierre Droz; Thomas Tursz; J L Amiel
[Factors of severity in placental choriocarcinoma].
Journal de gynécologie, obstétrique et biologie de la reproduction 1982;11(4):487-9.
1982: M Brin; Jean Pierre Droz; J M Caillaud; D Bellet; J L Amiel; G Brulé
[Cerebral metastases of malignant germinal tumors of the testis].
Journal d'urologie 1982;88(6):345-7.
1982: F Ben Ayed; D Bellet; N Badri; M Spielmann; Jean Pierre Droz; Thomas Tursz; J L Amiel
[Recurrences of placental choriocarcinoma].
Journal de gynécologie, obstétrique et biologie de la reproduction 1982;11(3):383-4.
1982: O Richer; Jean Pierre Droz; G Lemoine; P Levasseur; J L Amiel; G Brulé
[Role of the excision of thoracic lesions in the treatment of metastatic malignant germinal tumors of the testis].
Journal d'urologie 1982;88(6):349-51.
1982: Thomas Tursz; F Ben Ayed; Jean Pierre Droz; M Spielmann; J L Amiel
[Salvage chemotherapy in resistant malignant lymphomas (author's transl)].
Bulletin du cancer 1982;69(1):28-32.
1981: J Rouesse; Thomas Tursz; Thierry Le Chevalier; D Huertas; J L Amiel; G Brule; B Callet; Jean Pierre Droz; P M Voisin; H Sancho-Garnier; J B Le Pecq; C Paoletti
[N-Methyl-9 hydroxy-ellipticine (NSC 264-137) in the treatment of malignant metastases. Preliminary results (author's transl)].
La Nouvelle presse médicale 1981;10(24):1997-9.
1981: F Ben Ayed; Jean Pierre Droz; J M Caillaud; J L Amiel
[Adult primary germ cell tumours outside the testes (author's transl)].
La Nouvelle presse médicale 1981;10(17):1389-91.
1980: J L Amiel; G Michel; Jean Pierre Droz; Thomas Tursz; F Ben Ayed
[Second laparotomy in cancers of the ovary treated with chemotherapy. 17 cases (author's transl)].
La Nouvelle presse médicale 1980;9(47):3605-8.
1980: F Ben Ayed; Jean Pierre Droz; J M Caillaud; J L Amiel
[Germinal tumours of the mediastinum in adults, without testicular lesion (author's transl)].
Annales de chirurgie 1980;34(8):623-5.
1980: J L Amiel; Jean Pierre Droz; Thomas Tursz; F Ben Ayed; J Gastiaburu; J Rouesse
[Cis-diamminated-dichloroplatinum (CDDP) in the chemotherapy of testicular dysembryomas and choriocarcinomas (author's transl)].
Journal d'urologie 1980;86(6):463-5.
1980: Jean Pierre Droz; F Ben Ayed; B Pascal; D Beurton; J Cukier; J L Amiel
[Therapeutic trials in inoperable carcinoma of the bladder (author's transl)].
Journal d'urologie 1980;86(6):479-81.